Skip to content

Effect of painting therapy on HBA1C

The effectiveness of painting therapy on HBA1C levels in children with type 1 diabetes (a clinical trial)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231201060230N1
Enrollment
60
Registered
2025-02-16
Start date
2025-04-21
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: For this group, 10 drawing therapy sessions will be held in groups of 10 children with type 1 diabetes in the endocrinology clinic of Amirkola Children's Hospital,

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 10 Years

Inclusion criteria

Inclusion criteria: Age 6 to 10 years (because at this age the child has objective thinking and meaningful painting and can paint his experiences). At least one year has passed since the diagnosis of diabetes. The signs of puberty have not appeared in the child. The child has not been to a painting class before. Willingness of parents and children to participate in the research.

Exclusion criteria

Exclusion criteria: Having a child with a physical or mental illness, except for diabetes. Hospitalization of the child at the time of the study. Child's physical inability to draw.

Design outcomes

Primary

MeasureTime frame
HBA1C level. Timepoint: control of HBA1C level will be done at the beginning of the study and after the completion of painting therapy. Method of measurement: through blood sampling and biochemical tests in the laboratory.

Secondary

MeasureTime frame
Total daily dose of insulin. Timepoint: Daily. Method of measurement: The daily insulin requirement is calculated by performing their algebraic sum.;Fasting blood sugar. Timepoint: Once a week, a total of 12 times. Method of measurement: Fasting blood sugar is measured with a glucometer. The three-month average at the time of the study is compared in the control and intervention groups. Fasting blood sugar is measured weekly in this study. In this study, Gala glucometer will be used to control blood sugar. Fasting blood sugar will be measured once a week by a Gala glucometer (12 times during the study) and the researcher will be informed by the family every Saturday through SMS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Morteza Alijanpour

Babol University of Medical Sciences

donyaabp830@gmail.com+98 11 3227 9552

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026